Connection

Gerardo Botti to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications Gerardo Botti has written about Xenograft Model Antitumor Assays.
Gerardo Botti
Connection Strength
0.087
Xenograft Model Antitumor Assays
  1. Pembrolizumab in lung cancer: current evidence and future perspectives. Future Oncol. 2019 Oct; 15(29):3327-3336.
    View in: PubMed
    Score: 0.047
  2. Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas. Sci Rep. 2017 05 02; 7(1):1312.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.